Related Experiment Video
Updated: May 11, 2026
07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
[Contraception and congenital heart disease]
Magalie Ladouceur1, Sarah Cohen, Maud Bidet
1Centre de référence des malformations cardiaques congénitales complexes (M3C), unit6 des cardiopathies cong6nitales de l'adulte, Hôpital européen Georges-Pompidou, service de cardiologie pédiatrique, Necker, 75015 Paris, France. magalie.ladouceur@gmail.com
La Revue Du Praticien
|May 22, 2013
Summary
Contraception counseling is vital for congenital heart disease patients. Progestin-only contraceptives are safer alternatives to combined hormonal contraceptives for women with severe heart conditions.
Area of Science:
- Cardiology
- Reproductive Health
- Pharmacology
Context:
- Adolescent and adult congenital heart disease (ACHD) programs require integrated contraception counseling.
- Cardiovascular safety and contraceptive efficacy are critical considerations for ACHD patients.
- Individualized contraceptive recommendations must balance patient acceptability, efficacy, and safety.
Purpose:
- To review the safety and efficacy of various contraceptive methods for women with congenital heart disease.
- To highlight the risks associated with estrogen-containing contraceptives in severe ACHD.
- To emphasize progestin-only methods as a viable alternative when estrogen is contraindicated.
Summary:
- Combined oral contraceptives (COCs), while highly effective and popular, carry thrombogenicity risks due to their estrogen component, making them unsuitable for many with severe congenital heart disease.
- Progestin-only contraceptives offer a safer alternative for women with contraindications to estrogen.
- The efficacy of progestin-only methods varies, necessitating careful selection based on individual patient profiles.
Impact:
- Improved contraceptive counseling and method selection for women with congenital heart disease.
- Reduced risk of thromboembolic events in this vulnerable population.
- Enhanced reproductive health outcomes for individuals with congenital heart disease.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...